UK markets open in 4 hours 5 minutes

Ayala Pharmaceuticals, Inc. (ADXS)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.5600-0.0650 (-10.40%)
At close: 03:56PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-48,072
-48,072
-38,013
-40,254
-30,146
Depreciation & amortisation
369
369
162
168
182
Stock-based compensation
1,223
1,223
2,244
2,684
1,569
Change in working capital
1,130
1,130
1,097
-954
854
Accounts receivable
234
234
-234
681
-212
Accounts payable
-724
-724
-472
-512
451
Other working capital
-29,485
-29,485
-34,510
-38,361
-27,586
Other non-cash items
9,866
9,866
-
-
-
Net cash provided by operating activities
-29,485
-29,485
-34,510
-38,356
-27,541
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-5
-45
Sales/maturities of investments
-
-
-
0
226
Other investing activities
4,037
4,037
-2
-
-
Net cash used for investing activities
5,946
5,946
-2
-5
181
Cash flows from financing activities
Common stock issued
20,001
20,001
512
33,229
52,641
Common stock repurchased
-
-
-615
-
-
Net cash used provided by (used for) financing activities
26,001
26,001
-103
33,330
52,922
Net change in cash
2,488
2,488
-34,615
-5,031
25,562
Cash at beginning of period
2,724
2,724
37,339
42,370
16,808
Cash at end of period
5,212
5,212
2,724
37,339
42,370
Free cash flow
Operating cash flow
-29,485
-29,485
-34,510
-38,356
-27,541
Capital expenditure
-
-
-
-5
-45
Free cash flow
-29,485
-29,485
-34,510
-38,361
-27,586